We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+8.24%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$778M
AUM Growth
+$41.1M
Cap. Flow
-$3.71M
Cap. Flow %
-0.48%
Top 10 Hldgs %
60.4%
Holding
78
New
1
Increased
28
Reduced
40
Closed
2

Top Buys

Rank Stock Value
1
CASY icon
Casey's General Stores
CASY
+$2.7M
2
PAYC icon
Paycom
PAYC
+$1.51M
3
DHR icon
Danaher
DHR
+$1.31M
4
LLY icon
Eli Lilly
LLY
+$1.3M
5
PANW icon
Palo Alto Networks
PANW
+$1.18M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.78M
2
NVDA icon
NVIDIA
NVDA
+$4.56M
3
AAPL icon
Apple
AAPL
+$1.7M
4
PEP icon
PepsiCo
PEP
+$1.55M
5
ADBE icon
Adobe
ADBE
+$557K

Sector Composition

Rank Sector Weight
1 Technology 42.96%
2 Healthcare 15.24%
3 Consumer Discretionary 13.12%
4 Communication Services 9.2%
5 Financials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADBE icon
51
Adobe
ADBE
$98.5B
$1.12M 0.14%
3,181
-1,553
-33% -$557K
QCOM icon
52
Qualcomm
QCOM
$160B
$1.06M 0.14%
6,383
-566
-8% -$89.8K
ADI icon
53
Analog Devices
ADI
$179B
$1.03M 0.13%
4,193
+70
+2% +$16.8K
MDLZ icon
54
Mondelez International
MDLZ
$80.5B
$804K 0.1%
12,975
-6,950
-35% -$448K
AMGN icon
55
Amgen
AMGN
$209B
$700K 0.09%
2,483
– –
DIS icon
56
Walt Disney
DIS
$167B
$573K 0.07%
5,030
-290
-5% -$34.2K
MSTR icon
57
Strategy Inc
MSTR
$35.7B
$517K 0.07%
1,605
+135
+9% +$50.1K
HSY icon
58
Hershey
HSY
$35.9B
$464K 0.06%
2,483
-60
-2% -$10.9K
EMR icon
59
Emerson Electric
EMR
$83.3B
$420K 0.05%
3,208
– –
TSLA icon
60
Tesla
TSLA
$1.22T
$385K 0.05%
865
+21
+2% +$7.28K
UNH icon
61
UnitedHealth
UNH
$383B
$384K 0.05%
1,113
+7
+0.6% +$2.12K
AFL icon
62
Aflac
AFL
$64.8B
$370K 0.05%
3,300
-216
-6% -$22.7K
CSCO icon
63
Cisco
CSCO
$448B
$368K 0.05%
5,413
-99
-2% -$6.75K
MRSH
64
Marsh
MRSH
$91.4B
$367K 0.05%
1,817
– –
ROK icon
65
Rockwell Automation
ROK
$52.4B
$344K 0.04%
984
+18
+2% +$6.22K
K
66
DELISTED
Kellanova
K
$329K 0.04%
4,010
– –
COF icon
67
Capital One
COF
$129B
$320K 0.04%
1,502
– –
STZ icon
68
Constellation Brands
STZ
$22.3B
$314K 0.04%
2,325
-3,069
-57% -$488K
NVS icon
69
Novartis
NVS
$301B
$285K 0.04%
2,227
-50
-2% -$6.1K
BRK.B icon
70
Berkshire Hathaway Class B
BRK.B
$1.1T
$263K 0.03%
522
-33
-6% -$16K
ENB icon
71
Enbridge
ENB
$121B
$254K 0.03%
5,087
+100
+2% +$4.71K
USB icon
72
US Bancorp
USB
$98B
$248K 0.03%
5,176
– –
KO icon
73
Coca-Cola
KO
$381B
$246K 0.03%
3,724
-178
-5% -$12.3K
PLTR icon
74
Palantir
PLTR
$293B
$238K 0.03%
+1,305
New +$211K
LIN icon
75
Linde
LIN
$235B
$236K 0.03%
497
-67
-12% -$31.7K
1 2
3
4

Similar funds

TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
SCM
SKBA Capital Management San Francisco, California $728M AUM 12.18% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return
TFHU
TLT Family Holdco ULC Toronto $724M AUM 24.23% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $724M AUM 52.97% 1-Year Est. Return

Dillon & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Dillon & Associates held 78 positions worth $778M, up 5.6% from $737M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 3.8%. Dillon & Associates opened 1 new position and exited 2, leaving the 78-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 41% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Dillon & Associates's largest Q3 2025 buy was Palantir: 1,305 shares worth $238K.
  • Dillon & Associates added most to Casey's General Stores in Q3 2025, an estimated $2.7M increase.
  • Dillon & Associates's biggest Q3 2025 reduction was Regeneron Pharmaceuticals, cutting an estimated $4.78M.
  • Dillon & Associates fully exited PayPal in Q3 2025, selling an estimated $251K.
  • Dillon & Associates's ten largest holdings make up 60% of its $778M portfolio in Q3 2025.
  • Dillon & Associates opened 1 new position and closed 2 in Q3 2025.
  • Dillon & Associates's portfolio value rose 5.6% quarter-over-quarter to $778M.

Based on Dillon & Associates's 13F filing for Q3 2025, filed 28 Oct 2025.